Malignant melanoma: To screen or not to screen? An evaluation of the Euromelanoma Day in Belgium

European Journal of Dermatology

Volumn 20, Issue 4, 2010, Pages 517-518

  Truyers, Carla ^a   Lesaffre, Emmanuel ^a   Kellen, Eliane ^b   Bartholomeeusen, Stefaan ^a   Aertgeerts, Bert ^a   Buntinx, Frank ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Centre for Preventive Medicine   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BELGIUM; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; GENERAL PRACTICE; HUMAN; LETTER; MASS SCREENING; MELANOMA; SEX RATIO; FEMALE; INCIDENCE; MALE; REGISTER; SKIN NEOPLASMS;

BELGIUM; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MELANOMA; REGISTRIES; SKIN NEOPLASMS;

EID: 77954729520     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.0969     Document Type: Letter

References (6)

1. www.euromelanoma.org, 2009.
2. Balch CM, Buzaid AC, Soong SJ, et al. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol 2001; 19: 3635-48.
3. Bartholomeeusen S, Truyers C, Buntinx F. Diseases in general practice in Flanders. Leuven: Academisch Centrum voor Huisartsgeneeskunde. KU Leuven, 2004.
4. Fuller WA. Introduction to statistical time series. 2 ed. John Wiley & Sons, 1996.
5. Hakama M, Coleman MP, Alexe DM, Auvinen A. Cancer screening: evidence and practice in Europe 2008. Eur J Cancer 2008; 44: 1404-13.
6. Vanstraelen D, Deleu H, Van Robays J, et al. Melanoma Incidence Trends in Limburg After Screening and Prevention Campaigns. Arch Public Health 2010 (Accepted).